Intravenous cardiac lead with improved fixation

Abstract: An intravenous lead (36; 110) for use with a cardiac device (30) implantable beneath the skin of a patient provides positive fixation for the lead when implanted in an artery or vein of the heart. The lead includes at least one electrode (44; 116) carried by the lead and adapted to be coupled to the implantable cardiac device. The lead includes a coiled section (39; 126) having a resiliently coiled configuration. The coiled section makes substantially continuous surface contact with inner wall surfaces of an artery or vein after the lead is implanted within the artery or vein for providing positive fixation of the lead.

Description: BACKGROUND OF THE INVENTION The present invention generally relates to an intravenous cardiac lead having an improved configuration for fixing the lead in a desired position within a vein or an artery after implantation. The present invention is more particularly directed to such an intravenous lead for use with an implantable atrial defibrillator which provides cardioverting electrical energy to the atria of the heart when the heart is in need of cardioversion. The intravenous cardiac lead of the present invention is particularly adapted for implantation in the coronary sinus of the heart and includes at least one electrode adapted to be within the coronary sinus or great vein of the heart and a second electrode adapted to be within the right atrium of the heart when the lead is fed into the heart to a preferred position to enable the sensing of atrial activity of the heart and the delivery of the cardioverting electrical energy to the atria. Atrial fibrillation is probably the most common cardiac arrhythmia. Although it is not usually a life threatening arrhythmia, it is associated with strokes thought to be caused by blood clots forming in areas of stagnant blood flow as a result of prolonged atrial fibrillation. In addition, patients afflicted with atrial fibrillation generally experience palpitations of the heart and may even experience dizziness or even loss of consciousness. Implantable atrial defibrillators have been proposed to provide patients suffering from occurrences of atrial fibrillation with relief. Unfortunately, to the detriment of such patients, none of these atrial defibrillators have become a commercial reality. Improved implantable atrial defibrillators and lead systems include an atrial fibrillation detector which, responsive to sensed atrial activity, determines when the atria of the heart are in need of cardioversion. When the atrial fibrillation detector determines that the atria are in fibrillation and thus in need of cardioversion, the atrial fibrillation detector causes a cardioverter stage to deliver defibrillating or cardioverting electrical energy to the atria in timed relation to a detected ventricular electrical activation (R wave) of the heart. As a result, the atria are automatically and safely cardioverted. The foregoing improved atrial defibrillator also includes an intravenous lead which reduces the quantity of electrical energy required to cardiovert or defibrillate the atria. The intravenous lead has an electrode adapted to be within the right atrium and another electrode adapted to be within the coronary sinus beneath the left atrium. The application of the cardioverting electrical energy across these electrodes not only reduces the energy required to cardiovert the atria, but also reduces the amount of energy applied to the ventricles. To place the electrodes in the positions noted above, the lead is fed down the superior vena cava, into the right atrium, through the coronary sinus ostium, and advanced into the coronary sinus. While the lead is preshaped to conform to the above noted path, it would be desirable to provide the lead with positive fixation since the blood flow through the coronary sinus is in a direction which tends to force the lead in a reverse direction with respect to the implantation feed path. Such positive fixation, however, must permit adequate blood flow through the coronary sinus and not cause occlusions. EP-A-0 085 417 discloses a biomedical stimulation lead wherein the lead body is formed into a helical configuration to assist in anchoring the lead. There is only one electrode and the conductor leading thereto is a coil. WO-A-92/21406 discloses a temporary cardiac lead including a flexible conductor and an electrode for establishing electrical contact with body tissue. A helical coil is secured to the electrode for frictionally resisting the movement of the lead relative to the body tissue. The present invention provides such positive fixation for an intravenous lead such as the lead described above. In accordance with the present invention, the lead fixation is provided by a preformed section of the lead which has a resiliently coiled configuration. After the lead is implanted within a vein or an artery, the preformed section is permitted to assume its coiled configuration for making substantially continuous surface contact with inner wall surfaces of the artery or vein in the region of the coiled section. Such surface contact fixes the lead in place. Thereafter, fibrous tissue which builds up around the lead assures permanent fixation. SUMMARY OF THE INVENTION The present invention therefore provides an intravenous lead for use with a cardiac device implantable beneath the skin of a patient as claimed in claim 1. The lead includes at least one electrode carried by the lead and adapted to be coupled to the implantable cardiac device. The lead also includes a coiled section adapted to make substantially continuous surface contact with inner wall surfaces of an artery or vein. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a side plan view of a lead embodying the present invention. Figure 2 is a partial, cross-sectional view, of the lead of Figure 1. Figure 3 is another side plan view of the lead of Figure 1 with a stylet inserted therein prior to implantation. Referring now to Figure 1, it illustrates, in side plan view, a lead 110 embodying the present invention. The lead 110 includes a proximal end 112 and a distal end 114. At the distal end 114 is an elongated electrode 116 which extends between a proximal electrode header 118 and a distal electrode header 120. At the proximal end 112, the lead 110 includes a connector 122 having a pin 124 which is coupled to the electrode 116 and which provides electrical connection to an implanted cardiac device, such as an atrial defibrillator. The lead 110 is particularly adapted for use with an atrial defibrillator and for disposing the electrode 116 in the coronary sinus and great cardiac vein of the heart. As will be noted in Figure 1, the lead 110 has a coiled configuration in a section 126 of the lead 110 which includes the elongated electrode 116. The coiled configuration of the lead 110 in the section 126 may be obtained in a manner as more clearly illustrated in Figure 2. Figure 2 is a partial cross-sectional view of the lead 110 within the section 126. More specifically, Figure 2 shows in cross section one coil turn of the coiled configuration of the lead 110 within the coiled section 126. The lead 110, as illustrated in Figure 2, includes an inner stylet coil 130, an outer electrically insulative jacket 132, and the elongated electrode 116. The stylet coil 130 is formed by a plurality of closely spaced small diameter turns of wire. The stylet coil 130 thus includes a central passageway 134 into which a stylet may be extended prior to and during the implantation of the lead 110. The outer jacket 132 is formed of an electrically insulative material such as polyurethane or silicone rubber. As will be noted in the figure, the insulative jacket 132 is coaxial with and overlies the inner stylet coil 130. The electrode 116, like the stylet coil 130, is also formed from a plurality of closely spaced turns of a conductive wire. The electrode 116 is preferably preformed with its closely spaced turns prior to being mounted upon the lead 110. To impart the coiled configuration to the lead 110 within the section 126 as illustrated in Figure 1, either the inner stylet coil 130 is coiled in a portion thereof corresponding to the section 126 having the coiled configuration or both the inner stylet coil 130 and the elongated electrode 116 are coiled therefor. To that end, the stylet coil 130 may be coiled to form a helix having comparatively widely spaced turns before the insulative jacket 132 is slid over the stylet coil 130. Similarly, the electrode 116 may be coiled to form a helix having comparatively widely spaced turns prior to the electrode 116 being slid over the insulative jacket 132. With either construction, the lead 110 within the section 126 will be imparted with a coiled configuration for making substantially continuous surface contact with inner wall surfaces of the artery or vein for retaining the lead within the artery or vein in which it is implanted. Referring now to Figure 3, Figure 3 illustrates the lead 110 having a stylet 140 inserted therein prior to the implantation of the lead 110. The stylet includes a stylet wire 142 and a stylet handle 144. As will be noted in Figure 3, when the stylet wire 142 is inserted through a funnel-shaped stylet guide 143 into the central passageway of the lead 110 formed by the stylet coil 130, the coiled section 126 is elongated so as to render the lead 110 feedable into the artery or vein of the heart. Once the lead is in its desired position, the stylet 142 is removed for releasing the elongation of the preformed coiled section 126 of the lead. As a result, the preformed coiled section 126, which, in accordance with this preferred embodiment, includes electrode 116, will make substantially continuous surface contact with inner wall surfaces of the artery or vein for retaining the lead 110 within the artery or vein. Hence, once the elongation of the preformed coiled section 126 is released, the section 126 is permitted to assume the coiled configuration. Further, the coiled configuration may be imparted to the lead 110 by either the stylet coil 130 being performed in a coiled configuration or by the stylet coil 130 and the electrode 116, both being preformed in a coiled configuration as previously described.

Claims: An intravenous lead (110) for use with a cardiac device (30) implantable beneath the skin of a patient, the lead including: at least one electrode (116) carried by the lead and adapted to be coupled to the implantable cardiac device, a lead section (126) having a coiled configuration for making substantially continuous surface contact with inner wall surfaces of an artery or vein after the lead body is fed into the artery or vein, an inner stylet coil (130), and an outer electrically insulative jacket (132) coaxial with and overlying the inner stylet coil, the lead characterized by the inner stylet coil (130) also being coiled to impart the form of the lead coiled section (126) to the lead. The lead (110) of claim 1 further characterized by the lead section (126) having a spiral configuration. The lead (110) of claims 1 or 2 further characterized by the at least one electrode (116) being an elongated electrode and the lead section (126) including the at least one electrode.

Inventors: ALFERNESS CLIFTON A, HELLAND JOHN R, ALFERNESS, CLIFTON A., HELLAND, JOHN R.
Applicants: CARDIAC PACEMAKERS INC, CARDIAC PACEMAKERS, INC.
Application year: 1993
Main classification: A61N1
IPC codes: A61N1